Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;37(6):853-861.
doi: 10.5114/ada.2019.82795. Epub 2019 Feb 5.

The whole truth about botulinum toxin - a review

Henryk Witmanowski  1 , Katarzyna Błochowiak  2
Affiliations
Review

The whole truth about botulinum toxin - a review

Henryk Witmanowski et al. Postepy Dermatol Alergol. 2020 Dec.

Abstract

Treatment with botulinum toxin is widely viewed as safe, effective and largely devoid of serious side effects. There are two classes of Botox-related adverse events - transient and benign events, and potentially serious events. The aim of this study was to provide an overview of Botox-related side effects and advise potential management and preventive strategies. Benign side effects are well-localized, reversible and self-limited complications which develop within a few days of the injection, and they usually disappear without any treatment. The aesthetic and functional adverse effects are associated with different muscle responses to botulinum toxin or with misplacement of botulinum toxin. The serious events are sequelae due to the systemic spread of toxin leading to botulism.

Keywords: aesthetic surgery; botulinum toxin; plastic surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology. 2015;95:65–9. - PubMed
    1. Field M, Splevins A, Picaut P, et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) neurotoxin content and potential implications for duration of response in patients. Toxins. 2018;10:535. - PMC - PubMed
    1. Omprakash HM, Rajendran SC. Botulinum toxin deaths: what is the fact? J Cutan Aesthet Surg. 2008;1:95–7. - PMC - PubMed
    1. Roy D, Sadick NS. Complications of botulinum toxin. Compl Cutan Surg. 2018:207–12.
    1. Shetty MK. Guidelines on the use of botulinum toxin type A. Indian J Dermatol Venereol Leprol. 2008;74(Suppl):S13–22. - PubMed